GlassScriptPhysician profile
Parag S Patel
NPI 1689751646
$24,169.15
in general payments reported to CMS, 2019-2025
81 companies · $3,998 in 2025
The $3,998 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,261 · 2020: $2,972 · 2021: $3,201 · 2022: $3,258 · 2023: $3,114 · 2024: $3,366 · 2025: $3,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,477.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,570.52 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $2,221.81 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $2,022.09 | 2019-2025 | |
| Pfizer INC. | $1,472.11 | 2019-2025 | |
| Amgen INC. | $1,313.05 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $1,298.53 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boston Scientific Corporation | $913.47 | 2019-2025 | Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $868.51 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Otsuka America Pharmaceutical, INC. | $850.24 | 2019-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Lilly USA, LLC | $777.92 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Abbott Laboratories | $633.81 | 2019-2025 | Freestyle Libre 3, Aveir |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $616.69 | 2019-2025 | Xifaxan, Trulance |
| Antares Pharma, INC. | $585.08 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Amarin Pharma, INC. | $556.17 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $499.13 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
Show all 81 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $472.54 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $375.26 | 2020-2025 | Austedo Xr, Austedo, Austedo Xr |
| Daiichi Sankyo INC. | $326.64 | 2020-2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $311.66 | 2019-2025 | Spravato, Xarelto |
| Lundbeck LLC | $298.31 | 2021-2025 | Rexulti |
| Abiomed | $282.87 | 2024-2025 | Impella |
| Kowa Pharmaceuticals America, INC. | $265.93 | 2019-2023 | Seglentis |
| Allergan, INC. | $256.33 | 2019-2021 | |
| Eisai INC. | $241.03 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $239.57 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $232.98 | 2019-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $227.32 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $204.53 | 2022 | |
| Phathom Pharmaceuticals, INC. | $192.45 | 2024-2025 | Voquezna |
| Ibsa Pharma INC. | $174.84 | 2019-2025 | Flector, Tirosint, Licart |
| Dexcom, INC. | $154.25 | 2022-2025 | Dexcom G6 Transmitter |
| Alkermes, INC. | $146.23 | 2022-2024 | Aristada, Lybalvi, Vivitrol |
| Biohaven Pharmaceuticals, INC. | $138.45 | 2021 | |
| Astellas Pharma US INC | $133.75 | 2023-2025 | Veozah, Vesicare |
| Exact Sciences Corporation | $120.89 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $120.02 | 2019-2025 | |
| Axsome Therapeutics, INC. | $117.29 | 2023-2025 | Auvelity |
| Dova Pharmaceuticals | $116.75 | 2021 | |
| Idorsia Pharmaceuticals US INC | $116.17 | 2022-2023 | Quviviq |
| Zoll Circulation INC | $112.60 | 2024 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Vanda Pharmaceuticals INC. | $110.27 | 2025 | Fanapt |
| Comsort, INC | $100.00 | 2019 | |
| Corium, LLC | $95.65 | 2023-2024 | Azstarys, Azstarys |
| Jazz Pharmaceuticals INC. | $94.15 | 2019-2021 | |
| Adlon Therapeutics L.P. | $91.48 | 2019-2021 | |
| Almatica Pharma LLC | $72.80 | 2022-2024 | Teriparatide, Loreev Xr |
| Collegium Pharmaceutical, INC. | $70.53 | 2020-2025 | Belbuca |
| Currax Pharmaceuticals LLC | $67.31 | 2019-2023 | Onzetra Xsail, Contrave, Nexlizet |
| Halozyme INC | $63.72 | 2023 | |
| Harmony Biosciences LLC | $61.31 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $48.24 | 2020-2022 | |
| Esperion Therapeutics, INC. | $42.69 | 2020-2024 | Nexletol |
| Kaleo, INC. | $41.30 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $40.59 | 2019-2021 | |
| Bausch Health US, LLC | $39.56 | 2019-2021 | |
| Vivus LLC | $38.32 | 2019-2021 | |
| Clarus Therapeutics INC. | $35.04 | 2021 | |
| Nevro Corp. | $31.82 | 2023 | Senza |
| Corcept Therapeutics | $31.39 | 2025 | Korlym |
| Neos Therapeutics, LP | $30.09 | 2024 | Adzenys Xr-Odt |
| Xeris Pharmaceuticals, INC. | $29.97 | 2021-2023 | Gvoke Hypopen |
| Endo Pharmaceuticals INC. | $28.73 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $27.65 | 2022 | |
| Sanofi Pasteur INC. | $27.55 | 2019-2022 | |
| Philips North America LLC | $24.87 | 2022 | |
| Hikma Pharmaceuticals USA | $24.05 | 2019-2020 | |
| Aytu Biopharma, INC. | $18.62 | 2020 | |
| Edwards Lifesciences Corporation | $18.25 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Verona Pharma, INC. | $18.16 | 2025 | Ohtuvayre |
| Si-Bone, INC. | $17.04 | 2024 | |
| Ucb, INC. | $16.15 | 2022 | |
| Intra-Sana Laboratories | $14.61 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Metuchen Pharmaceuticals | $14.51 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $14.47 | 2019 | |
| Neurocrine Biosciences, INC. | $13.73 | 2022 | |
| Radius Health, INC. | $13.45 | 2023 | |
| Redhill Biopharma INC. | $13.20 | 2021 | |
| Fidia Pharma USA INC. | $12.98 | 2023 | Hymovis |
| Horizon Therapeutics Plc | $12.73 | 2019 | |
| Genentech USA, INC. | $12.37 | 2022 | |
| Seqirus USA INC | $12.01 | 2019 |
Drugs and devices associated with these payments
Rexulti $794Ozempic $699Farxiga $680Rybelsus $607Airsupra $603Breztri $603Vraylar $518Nurtec Odt $504Watchman Flx $497Jardiance $449Freestyle Libre 3 $437Evenity $410Zavzpret $386Wegovy $345Qulipta $339Ubrelvy $328Trelegy Ellipta $258Aristada $252Prolia $238Kerendia $227Zepbound $227Mounjaro $210Xifaxan $196Voquezna $192Xyosted $178Repatha $171Otezla $171Calquence $169Austedo Xr $152Tradjenta $147Lybalvi $134Dexcom G6 Transmitter $126Veozah $118Aveir $118Auvelity $117Therox Ds2 Console $113Catheter $113Downstream Cartridge $113Fanapt $110Arexvy $96.60Azstarys $95.65Emgality $91.21Shingrix $90.60Prevnar 20 $87.18Comirnaty $87.18Cologuard Collection Kit $86.70Synjardy $82.52Quviviq $75.35Tirosint $65.44Abilify Asimtufii $63.21Wakix $61.31Paxlovid $60.58Abrysvo $57.11Austedo $53.47Trulicity $52.40Licart $50.92Gardasil 9 $50.53Abilify Maintena $49.81Vyndaqel $49.56Trijardy Xr $47.54Glyxambi $47.54Trintellix $47.05Leqvio $43.89Impella $37.33Flector $36.40Entresto $34.69Capvaxive $34.22The Cologuard Plus Collection Kit $34.19Watchman Access System $32.07Senza $31.82Teriparatide $31.41Loreev Xr $31.41Korlym $31.39Seglentis $30.68Adzenys Xr-Odt $30.09Nexletol $26.89Eliquis $25.47Rinvoq $24.10Tzield $19.63Edwards Sapien 3 Ultra Transcatheter Heart Valve $18.25Ohtuvayre $18.16Spravato $17.87Krystexxa $17.26Belsomra $16.36Proquad $16.31Saxenda $16.04Ajovy $15.97Xarelto $15.45Belbuca $15.43Vesicare $15.28Gvoke Hypopen $15.27Reltone 400 Mg $14.61Glycate $14.61Reltone 200 Mg $14.61Viberzi $14.47Nocdurna $13.71Tlando $13.71Injectafer $13.62Nexlizet $13.61Onzetra Xsail $13.61
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parag Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.